Clinical Trial Update: Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating induction and maintenance of castration with subcutaneous triptorelin pamoate in prostate cancer patients has completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• triptorelin pamoate (triptorelin pamoate)

Snippet

Sponsor: Ipsen | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-10-28